NEW YORK (GenomeWeb) – Synthetic DNA firm Twist Bioscience announced today the completion of a $37 million Series C financing round. 

The round was led by Illumina. New investors Fidelity Management and Research and Foresite Capital Mangement also participated in the round, as did all existing investors including Nick and Joby Pritzker through their family's firm Tao Invest; Arch Invest Venture Partners; Paladin Capital Group; Yuri Milner; and other corporate and venture investors. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.